Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,105,093
-$3,703,787 QoQ
Shares Held
126,706
+16.9% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#245
of 1,412 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $86,377,339 across 19 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,946 | $29,653,938 | |
| 2 | ALKS |
Alkermes plc.
|
335,208 | $17,564,899 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
26,450 | $14,331,403 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
126,706 | $9,105,093 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
305,441 | $5,485,720 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
141,698 | $3,473,017 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
95,081 | $2,339,943 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40,850 | $1,383,998 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,105,093 | 126,706 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,808,880 | 108,357 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $12,657,492 | 100,600 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $15,569,911 | 106,410 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $17,170,095 | 110,100 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $19,970,892 | 121,293 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $47,716,168 | 292,863 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $72,514,700 | 371,147 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $68,852,351 | 397,164 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $73,158,281 | 432,352 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $79,871,691 | 404,680 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $59,109,878 | 339,751 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $59,249,539 | 344,054 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $55,907,196 | 335,900 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $46,780,518 | 319,212 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $41,694,847 | 281,171 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $41,000,406 | 238,527 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $48,053,674 | 254,805 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $67,845,220 | 278,020 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $47,383,749 | 244,070 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $41,391,860 | 222,107 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $35,922,605 | 228,109 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $27,968,672 | 168,995 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $52,457,844 | 317,215 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $36,723,019 | 267,973 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $28,688,467 | 243,763 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||